Finally, B-lymphoid tyrosine kinase (BLK) expression in nodal PTCL should be evaluated, as it is commonly found in CTCL, and dasatinib showed some degree of effectiveness in such instances (73). This evidence concerns the gene BLK and primary cutaneous T-cell non-Hodgkin lymphoma.